Publication
Research Papers : 2017
- The application of a specific morphinan template to the synthesis of galanthamine.
Yamamoto, N.; Okada, T.; Harada, Y.; Kutsumura, N.; Imaide, S.; Saitoh, T.; Fujii, H.; Nagase, H.
Tetrahedron, 2017, 73, 5751−5758.
- Deprotection of silyl ethers by using SO3H silica gel: Application to sugar, nucleoside, and alkaloid derivatives.
Fujii, H.; Shimada, N.; Ohtawa, M.; Karaki, F.; Koshizuka, M.; Hayashida, K.; Kamimura, M.; Makino, K.; Nagamitsu, T.; Nagase, H.
Tetrahedron, 2017, 73, 5425−5429.
- C-Homomorphinan Derivatives as Lead Compounds to Obtain Safer and More Clinically Useful Analgesics.
Ishikawa, K.; Karaki, F.; Tayama, K.; Higashi, E.; Hirayama, S.; Itoh, K.; Fujii, H.
Chem. Pharm. Bull., 2017, 65, 920-929.
- Reactivity of 7-Azanorbornenes in Bioorthogonal Inverse Electron-Demand Diels–Alder Reactions.
Karaki, F.; Ohgane, K.; Imai, H.; Itoh, K.; Fujii, H.
Eur. J. Org. Chem., 2017, 2017, 3815-3829.
- Design and synthesis of novel δ opioid receptor agonists with an azatricyclodecane skeleton for improving blood-brain barrier penetration.
Watanabe, Y.; Hayashida, K.; Saito, D.; Takahashi, T.; Sakai, J.; Nakata, E.; Kanda, T.; Iwai, T.; Hirayama, S.; Fujii, H.; Yamakawa, T.; Nagase H.
Bioorg. Med. Chem. Lett., 2017, 27, 3495-3498.
- Phenanthridin-6-one derivatives as the first class of non-steroidal pharmacological chaperones for Niemann-Pick disease type C1 protein.
Fukuda, H.; Karaki, F.; Dodo, K.; Noguchi-Yachide, T.; Ishikawa, M.; Hashimoto, Y.; Ohgane, K.
Bioorg. Med. Chem. Lett., 2017, 27, 2781-2787.
- Novel delta opioid receptor agonists with oxazatricyclodecane structure showing potent agonistic activities.
Hayashida, K.; Hirayama, S.; Iwai, T.; Watanabe, Y.; Takahashi, T.; Sakai, J.; Nakata, E.; Yamakawa, T.; Fujii, H.; Nagase H.
Bioorg. Med. Chem. Lett., 2017, 27, 2742-2745.
- Effects of repeated treatment with a delta opioid receptor agonist KNT-127 on hyperemotionality in olfactory-bulbectomized rats.
Gotoh, L.; Saitoh, A.; Yamada, M.; Fujii, H.; Nagase, H.; Yamada, M.
Behav. Brain Res., 2017, 323, 11-14.
- Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies.
Nagase, H.; Yamamoto, N.; Yata, M.; Ohrui, S.; Okada, T.; Saitoh, T.; Kutsumura, N.; Nagumo, Y.; Irukayama-Tomobe, Y.; Ishikawa, Y.; Ogawa, Y.; Hirayama, S.; Kuroda, D.; Watanabe, Y.; Gouda, H.; Yanagisawa, M.
J. Med. Chem., 2017, 60, 1018-1040.
- Hepatic dipeptidyl peptidase-4 controls pharmacokinetics of vildagliptin in vivo.
Asakura, M.; Fukami, T.; Nakajima, M.; Fujii, H.; Atsuda, K.; Itoh, T.; Fujiwara, R.
Drug Metab. Dispos., 2017, 4, 237.
Copyright (C) 2008 Laboratory of Medicinal Chemistry. All rights reserved.